Buprenorphine Sublingual C-III
NDC 72189-580, Buprenorphine Sublingual C-III, tablet, from Direct_Rx.
- Product NDC
- 72189-580
- Status
- Listed
- Labeler
- Direct_Rx
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078633
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/72189-580 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72189-580-60 | 72189058060 | 60 TABLET in 1 BOTTLE (72189-580-60) |
| 72189-580-90 | 72189058090 | 90 TABLET in 1 BOTTLE (72189-580-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/22412030-a641-28d8-e063-6294a90a2fef
Use it
Look up 72189-580 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72189-580 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72189-580. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.